WHAT TO EXPECT AT THE EVENT:

The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, hosted by the American Association for Cancer Research (AACR), the National Cancer Institute (NCI), and the European Organisation for Research and Treatment of Cancer (EORTC), brings together academics, scientists, regulatory agency staff, investors, and biotech and pharmaceutical industry representatives. The event focuses on innovations in drug development, target selection, the impact of new discoveries in cellular and molecular biology, translational research, and early clinical trials.

MEET US AT BOOTH #208

As a trusted global CRO partner supporting oncology drug discovery and development from early concept through IND-enabling studies, ChemPartner brings deep expertise in complex modalities including advanced tumor models, oligonucleotide synthesis and assays, bispecific antibody-drug conjugates (BsADCs), ADC engineering and conjugation, in vitro and in vivo assays, and integrated platforms. Our multidisciplinary teams deliver data-driven insights, aligned with your research stage through flexible modular or integrated collaborations.

Connect with Kevin Riley, Carlo Petruzziello, and Neil Patel from ChemPartner’s Business Development team to discuss how our collaborative approach and scientific expertise can accelerate your next oncology breakthrough.

Let’s Connect